-- Hebei Changshan Biochemical Pharmaceutical (SHE:300255) は、ベラルーシの医薬品規制当局からダルテパリンナトリウム注射剤の医薬品登録証明書を取得した。
この薬剤は、急性深部静脈血栓症および不安定冠動脈疾患の治療に用いられる。
-- Hebei Changshan Biochemical Pharmaceutical (SHE:300255) は、ベラルーシの医薬品規制当局からダルテパリンナトリウム注射剤の医薬品登録証明書を取得した。
この薬剤は、急性深部静脈血栓症および不安定冠動脈疾患の治療に用いられる。
Indian benchmark indices ended largely unchanged on Thursday as gains driven by earnings-related buying offset broader market weakness.The BSE Sensex fell 114.00 points, or 0.2%, to close at 77,844.52, while the NSE Nifty 50 slipped 4.30 points, or 0.02%, to settle at 24,326.65.Expectations of easing tensions between the US and Iran further supported investor sentiment. Tehran is reportedly reviewing the latest U.S. proposals aimed at ending the conflict.In corporate developments, Bharat Forge (NSE:BHARATFORG, BOM:500493) reported a decline in consolidated profit in fiscal Q4 to 2.33 billion rupees from 2.83 billion rupees a year earlier. Revenue from operations, however, rose to 20.3 billion rupees from 17.0 billion rupees.Larsen & Toubro (NSE:LT, BOM:500510) gained after its buildings and factories business secured three large orders from a real estate client for projects across three states, according to a filing. The company classifies large orders in the range of 25 billion rupees to 50 billion rupees.
Two of Heilongjiang ZBD Pharmaceutical's (SHA:603567) products won bids from China's procurement program for traditional medicines, according to a Thursday filing with the Shanghai bourse.The products include ZBD's quick-acting sugar syrup for children, indicated for fever and sore throat, and its Xiangdan injection for angina pectoris or chest pain, the filing said.
Fortinet (FTNT) has an average rating of hold and mean price target of $102.03, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)